Biosimilars Market Research Report - Forecast to 2023 Global Biosimilars Market to Bolster Driven by Growing Pet Humanization
CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)
Biosimilars Market Research Report - Forecast to 2023
• A Biosimilar is described as a biological, medical product which is an identical copy of the original medical product. Market Research Future (MRFR) has published and released a research report about the global biosimilars market that predicts massive enlargement for this market with 26% CAGR during the forecast period between 2016 and 2023. In terms of cash, the market has been anticipated to rise to the US $ 16.97 bn. • Analyzing the market structure, this report estimates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market. This report also covers insights on the major countries/regions in which this industry is flourishing, along with the list and description of untapped regions which could be the potential markets in the future. • The key factors aiding the growth of the global biosimilars market include clinical trial activities for biosimilars, increasing demand for the cheap medical products, increasing incident of different diseases, and strategic collaborations resulting in enhanced productivity. However, lack of awareness and physician skepticism are the major restraining factor regarding market growth. Browse Report Details @ https://www.marketresearchfuture.com/reports/biosimilars-market-1329
2
www.marketresearchfuture.com
Biosimilars Market Research Report - Forecast to 2023 Segmentation: Industry News •
IMundipharma, a network of independent pharma companies, has acquired Spanish biosimilars development company Cinfa Biotech. The deal gives Mundipharma, access to a biosimilar to Amgen’s Neulasta (pegfilgrastim). 10 OCT 2018
•
The new white paper issued by the Association of European Cancer Leagues, a nonprofit, pan-European organization of national and regional cancer societies, has called for the greater use of biosimilars as a means to increase patient access to cancer treatment, and reduce costs. 10 OCT 2018.
Segmentation
• The segmentation global biosimilars market is on the basis of application, manufacturing, product, and region. The application based segmentation segments the market into blood-related disorders, immunity-related diseases, oncology, and other. Based on manufacturing, the market has contract manufacturing and in-house manufacturing. As per segmentation based on product, the market has been segmented into recombinant glycosylated proteins, recombinant non-glycosylated proteins, and others. Recombinant glycosylated proteins have been further segmented into Monoclonal antibody (mAb) and EPO. Recombinant non-glycosylated proteins have been further segmented into growth hormones, insulin, and other. Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1329
3
www.marketresearchfuture.com
Biosimilars Market Research Report - Forecast to 2023 Application & Major Players in this Research: Biosimilars Market Prominent Players: The key players in the global biosimilars market include Accord Healthcare (UK), Amgen Inc. (USA), Astra Zeneca (UK), Biocon Ltd. (India), Celltrion, Inc. (South Korea), Dr. Reddy’s Laboratories Ltd. (India), Eli Lilly (USA), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis (Switzerland), Pfizer Inc. (USA), Samsung Bioepis (South Korea), Sandoz International GmbH (Germany), and Teva Pharmaceuticals Industries Ltd. (Israel).
Get Discount @ https://www.marketresearchfuture.com/check-discount/842
4
www.marketresearchfuture.com
Biosimilars Market Research Report - Forecast to 2023 Major TOC in this Research:
• Chapter 1. Report Prologue • Chapter 2. Market Introduction • Chapter 3. Research Methodology • Chapter 4. Market Dynamics • Chapter 5. Market Factor Analysis • Chapter 6. Biosimilars Market , By Type • Chapter 7. Biosimilars Market , By Application • Chapter 8. Biosimilars Market, By Regions • Chapter 9. Competitive Landscape • Chapter 10. Company Profile • Chapter 11. Conclusion • Chapter 12. Appendix
5
www.marketresearchfuture.com
Biosimilars Market Research Report - Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), ContinuousFeed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright Š 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future.
6
www.marketresearchfuture.com
THANK YOU
MARKET RESEARCH FUTURE
salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
7
www.marketresearchfuture.com